FAQ

ARC19499

 

Topic mentions per year

Topic mentions per year

2010-2014
0120102014

Related topics

Related topics

1 relation
BAX499

Related mentions per year

Related mentions per year

2010-2016
201020122014201620182020
ARC19499
BAX499

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: studies of spatial dynamics of fibrin clot formation in hemophilia A.
BACKGROUND In recent years, a number of tissue factor pathway inhibitor (TFPI) antagonists have been developed to serve as… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor.
INTRODUCTION Promoting thrombin generation by inhibiting tissue factor pathway inhibitor (TFPI) is a potentially viable… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2011
2011
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
Hemophilia A and B are caused by deficiencies in coagulation factor VIII (FVIII) and factor IX, respectively, resulting in… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
2011
2011
THROMBOSIS AND HEMOSTASIS Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
Hemophilia A and B are caused by deficiencies in coagulation factor VIII (FVIII) and factor IX, respectively, resulting in… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
2010
2010
Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood
Background Hemophilia A and B are disorders resulting from a deficiency in factor VIII (FVIII), and factor IX (FIX), respectively… (More)
Is this relevant?